Biovail Takes Over Valeant via Reverse Merger to Expand Business Model

By Heather Cartwright

Pharma Deals Review: Vol 2010 Issue 7 (Table of Contents)

Published: 8 Sep-2010

DOI: 10.3833/pdr.v2010.i7.1366     ISSN: 1756-7874

Section: Mergers & Acquisitions



Biovail, Canada’s largest publicly owned pharmaceutical company, is to take over US-based Valeant Pharmaceuticals International in a transformational deal, valued at approximately US$3...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details